Stock Ownership/CRISPR THERAPEUTICS AG

CRISPR THERAPEUTICS AG: Ownership & Insider Activity

Hedge funds and institutional managers reporting a position in CRISPR THERAPEUTICS AG. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.

Reported Holders
14
13F filers
Aggregate Value
$240.5M
Across holders
Last Price
EOD close
Sector
GICS
Institutional Holders of CRISPR THERAPEUTICS AG
14 holders
ManagerTypeSharesMarket Value% of Total% of PortfolioActionQoQ ChangeQuarter
TWO SIGMA INVESTMENTS, LP
CIK 0001179392
Hedge Fund1.99M$108.5M45.1%0.1%Added+$27.6MQ2 2026
SHAW D E & CO INC
CIK 0001009207
Hedge Fund894K$48.7M20.3%0.0%Added+$41.0MQ2 2026
CITADEL ADVISORS LLC
CIK 0001423053
Hedge Fund466K$25.4M10.6%0.0%Added+$4.1MQ2 2026
MILLENNIUM MANAGEMENT LLC
CIK 0001273087
Hedge Fund382K$20.8M8.7%0.0%Added+$265KQ2 2026
Squarepoint Ops LLC
CIK 0001642575
Hedge Fund287K$15.6M6.5%0.0%Added+$15.1MQ2 2026
Rockefeller Capital Management L.P.
CIK 0001739439
Hedge Fund102K$5.5M2.3%0.0%Added$-2.4MQ2 2026
Fisher Asset Management, LLC
CIK 0000850529
Institutional Manager78K$4.3M1.8%0.0%NewQ2 2026
Man Group plc
CIK 0001637460
Hedge Fund73K$4.0M1.7%0.0%Reduced$-920KQ2 2026
TUDOR INVESTMENT CORP ET AL
CIK 0000923093
Hedge Fund43K$2.3M1.0%0.0%Added+$1.0MQ2 2026
ExodusPoint Capital Management, LP
CIK 0001736225
Hedge Fund29K$1.6M0.7%0.0%NewQ2 2026
110 of 14
1 / 2